Compare
Mettler Toledo International Inc vs Bruker Corp vs Waters Corp vs Bio-Rad Laboratories, Inc.
| Latest fiscal year | Mettler Toledo International Inc MTD | Bruker Corp BRKR | Waters Corp WAT | Bio-Rad Laboratories, Inc. BIO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.03B | $3.44B | $3.17B | $2.58B |
| Revenue growth (YoY) | +4.0% | +2.1% | +7.0% | +0.7% |
| Gross margin | 59.4% | 45.9% | 59.3% (computed) | 51.9% |
| Operating margin | n/a | 2.0% | 25.4% | 1.8% |
| Net margin | 21.6% | -0.2% | 20.3% | 29.4% |
| Net income | $869.19M | -$8.30M | $642.63M | $759.90M |
| EPS (Diluted) | $42.05 | -$0.15 | $10.76 | $27.85 |
| Operating cash flow | $955.77M | $134.10M | $652.55M | $532.20M |
| Free cash flow | $848.65M | $43.30M | $539.81M | $374.60M |
| Cash & equivalents | n/a | $298.80M | $587.83M | $529.80M |
| Total assets | $3.71B | $6.24B | $5.08B | $10.58B |
| Total liabilities | $3.74B | $3.73B | $2.52B | $3.12B |
| Shareholders' equity | -$23.64M | $2.47B | $2.56B | $7.45B |
| Return on year-end equity | n/a | -0.3% | 25.1% | 10.2% |
| Shares outstanding | 20.36M | 152.14M | 59.55M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Mettler Toledo International Inc | Bruker Corp | Waters Corp | Bio-Rad Laboratories, Inc. |
|---|---|---|---|---|
| Latest | $4.03B Ended 2025-12-31 | $3.44B Ended 2025-12-31 | $3.17B Ended 2025-12-31 | $2.58B Ended 2025-12-31 |
| 1 year earlier | $3.87B Ended 2024-12-31 | $3.37B Ended 2024-12-31 | $2.96B Ended 2024-12-31 | $2.57B Ended 2024-12-31 |
| 2 years earlier | $3.79B Ended 2023-12-31 | $2.96B Ended 2023-12-31 | $2.96B Ended 2023-12-31 | $2.67B Ended 2023-12-31 |
| 3 years earlier | $3.92B Ended 2022-12-31 | $2.53B Ended 2022-12-31 | $2.97B Ended 2022-12-31 | $2.80B Ended 2022-12-31 |
| 4 years earlier | $3.72B Ended 2021-12-31 | $2.42B Ended 2021-12-31 | $2.79B Ended 2021-12-31 | $2.92B Ended 2021-12-31 |